positive

Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar

Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar

Biogen Inc. (NASDAQ: BIIB) announced today that the outcome of its large clinical trial consisting of 856 patients regarding an Alzheimer’s drug produced positive results. Together with its Japanese partner, Eisai Co., the experimental dr..